Health
Novel vectors reduce the risks associated with ocular gene therapies – News-Medical.net
Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development.
Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development. Novel gene vectors now achieve widespread gene delivery and reduce the risks associated with these approaches.
The incidence of genetic mutations that result in rapid deterioration of the ability to see is larger than is generally supposed. For example, on the order of five million people around the world suffer from congenital retinal dystrophies, which often lead…
-
Business20 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General14 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News17 hours agoTips to improve engagement – Proctor
-
Noosa News20 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland